🔬"We need to find new ways of diagnosing infections and actually start using those in practice." Professor Graham Cooke (Graham Cooke) NIHR Imperial BRC says research is key to tackling AMR. Read more at Imperial NHS 💙 👉 imperial.nhs.uk/antimicrobial-…

Pleased to present CHANTS study #iNTS human challenge model with Malick Gibani and Anna Rydlova at Take on Typhoid conference in #Kigali #Rwanda

This was such an exciting talk .... the #iNTS CHANTS study CHIM is fully up and running! Congratulations! Can't wait for the data to unfold in the coming months!

A comprehensive up to date review in nature on all things #Typhoid fever from an international group of experts exploring latest knowledge and progress on typhoid control. It will be a fantastic resource for students, clinicians and academics alike with some beautiful figures!

Have a look at our protocol paper for the CHANTS study. More great work from Chris Smith. Comments and queries welcome. Pleased to have started recruitment and a busy year ahead. ‘The real work starts tomorrow’ Imperial Department of Infectious Disease HIC-Vac bmjopen.bmj.com/content/14/1/e…

🚨 MRC-funded 3 yr clinical research fellow (PhD) position available. Translational project involving 'first-in-man' study of human viral challenge in bronchiectasis. Supervised by myself Anand Shah with wider team inc. James D Chalmers and Tom Wilkinson. imperial.ac.uk/jobs/descripti…

New long term efficacy data on #typhoid conjugate #vaccines are out The Lancet. - 1 dose of vaccine - >4 years of follow up - in children 9mo - 12yrs - 78.3% efficacy - Millions of children potentially protected Take on Typhoid UMSOM Center for Vaccine Dev. & Global Health Malawi Liverpool Wellcome Programme thelancet.com/journals/lance…

Massive credit and kudos to Priyanka Patel, the diligent dynamo behind this important result, online in the Lancet today. Typhoid Conjugate Vaccines give durable protection for at least 4 years, across all age-groups from 9 months to 12 years old. thelancet.com/journals/lance…

Estimating the subnational prevalence of #AMR in #Typhoid and #Paratyphoid Take on Typhoid thelancet.com/journals/langl…

Nature Microbiology asked me to write a personal piece on 25yrs of #iNTS vaccine research. What does sustainable success look like, in the face of huge inequities? I reflected a bit on humility in facing Global Health challenges. rdcu.be/dzKr0 (free text access link)

Really excited to be involved in this programme to mentor talented research fellows addressing issues related to AMR in west Africa 😄 University awarded £1.3m Fleming Fund news.liverpool.ac.uk/2024/04/19/uni…

#Salmonella can be life-threatening for vulnerable populations. On #WIW2024, we revisit this Q&A with Imperial Department of Infectious Disease's Dr Malick Gibani, who explains how human challenge studies can tackle its global impact and support #vaccine development. Read 👉 imperial.ac.uk/news/237380/ho…

Preventing the next pandemic by deliberately infecting people? "The rewards of getting this right can be enormous." Chris Chiu and colleagues explain how #HumanChallenge studies could help accelerate vaccine development, in Telegraph Global Health Security 👇 telegraph.co.uk/global-health/…

"HIC-Vac is enabling progress to be made in areas that were previously static." Peter Openshaw explains how HIC-Vac, an international network of researchers, aims to reduce the burden of major infectious diseases by developing #HumanChallenge studies 👇 imperial.ac.uk/news/253874/hi…

Tackling the growing threat of antimicrobial resistance requires all the tools we have at our disposal — including vaccines. Charlie Weller explains more ⤵️ wellcome.org/news/vaccines-…

📣please retweet-We’re looking for an enthusiastic clinical fellow interested in infectious diseases and immunity in kids! #strepA #iSpynetwork 👇 imperial.ac.uk/jobs/search-jo…

Our researchers are at the forefront of combatting #hepatitis. Ahead of #WorldHepatitisDay, learn how their work has significantly contributed to its elimination strategies. Featuring Prof Graham Cooke and Imperial School of Public Health's Dr Shevanthi Nayagam 👇 imperial.ac.uk/news/255118/ta…

I'm so excited that we finally have vaccines that are protective against severe #RSV disease. I started working on immunity and pathology in #rsv disease in 1985, and here it is!